Terms and Conditions of Use

This website (the “Site”) is provided by CRISPR Therapeutics for the convenience of visitors to the Site. Nothing on the Site should be construed as an offer to form a binding contract, or as granting any license or transfer of intellectual property. Your use of the Site is at your own risk. Notwithstanding any other provision herein, CRISPR Therapeutics reserves the right, in the event of a violation of these terms and conditions, to protect its rights, property and interests to the maximum extent of the law.

Please read these Terms and Conditions of Use (the “Terms of Use”) carefully before using the Site. By accessing and using the Site, you agree to the Terms of Use. If you do not agree to these Terms of Use, you are not authorized to use the Site and you must immediately cease using the Site.

CRISPR Therapeutics reserves the right, at its sole discretion, to modify, add or remove portions of the Site, including the Terms of Use, at any time. You are bound by any revisions to the Terms of Use; therefore, please check these Terms of Use periodically for changes. Your continued use of the Site following the posting of changes to the Terms of Use means that you accept such changes.

No Unlawful or Prohibited Use

As a condition of your use of the Site, you agree to not use the Site for any purpose that is unlawful or prohibited by these Terms of Use. The Site may not be used in any manner that could damage, disable, overburden or impair the Site, or interfere with any other entity’s use of the Site. No content from the Site may be downloaded or otherwise exported in violation of United States law.

Scope of Use

The content on the Site is provided by CRISPR Therapeutics as a service to the general public and is for informational purposes only. A single copy of the Site may only be viewed, used, or downloaded for your personal, non-commercial use. Except as otherwise provided in these Terms of Use, no part of the Site may be copied, downloaded or stored in a retrieval system for any other purpose, nor may it be redistributed for any purpose, without CRISPR Therapeutics’ written permission.

Nothing on the Site should be construed as the giving of advice or the making of a recommendation regarding any decision or action related to your health or the health of others. If you are a patient, you should consult a doctor or other qualified healthcare professional regarding any questions you have about your health or before making any treatment decisions. If you are a doctor or other qualified healthcare professional, you should not allow the information on the Site to substitute for your own medical judgment, which you should exercise in evaluating the information on the Site.

Intellectual Property Rights; No Licenses

The Site, and the information which it contains, is the property of CRISPR Therapeutics AG and its affiliates and licensors, and is protected from unauthorized copying and dissemination by United States copyright law, international conventions and other intellectual property laws. The trademarks and logos displayed on this website are trademarks of CRISPR Therapeutics and its affiliates except as otherwise noted. Nothing on the Site should be construed to grant any license or right in or to any trademarks, logos or other intellectual property rights. All rights are reserved by the owners of each trademark, service mark, logo, or other intellectual property, except as otherwise described in this notice

No modification, transmission, distribution or reproduction of the content, including without limitation the code, contained in the Site, is permitted without CRISPR Therapeutics’ prior written permission.

Use of the Site does not grant any right or license under any copyright, trademark, trade secret, patent or other intellectual property rights.

Privacy

If you submit any information (including personal information) at or through the Site, such information will be subject to the CRISPR Therapeutics privacy policy, which is at available through the Site. The sender of any information to CRISPR Therapeutics is solely responsible for its content, including, without limitation, its accuracy, truthfulness and non-infringement of any other person's legal rights.

Dated Information

Certain information presented on the Site is or was current as of the “last revised” date shown on a particular page or pages of the Site. While CRISPR Therapeutics may periodically update or correct information presented on the Site, such information may include typographical errors and/or technical inaccuracies and/or omissions. CRISPR Therapeutics makes no representation or warranty as to the accuracy of any information at the Site and expressly disclaims any obligation to update such information. CRISPR Therapeutics also reserves the right to make additions, deletions or modifications to any information at any time and from time to time without any prior notice.

Forward Looking Statements

The Site contains a number of “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding CRISPR Therapeutics’ expectations about any or all of the following: (i) clinical trials (including, without limitation, the timing of filing of clinical trial applications and INDs, any approvals thereof and the timing of commencement of clinical trials), development timelines and discussions with regulatory authorities related to product candidates under development by CRISPR Therapeutics and its collaborators; (ii) the number of patients that will be evaluated, the anticipated date by which enrollment will be completed and the data that will be generated by ongoing and planned clinical trials, and the ability to use that data for the design and initiation of further clinical trials; (iii) the scope and timing of ongoing and potential future clinical trials; (iv) the intellectual property coverage and positions of CRISPR Therapeutics, its licensors and third parties; (v) the sufficiency of CRISPR Therapeutics’ cash resources; and (vi) the therapeutic value, development, and commercial potential of CRISPR/Cas9 gene editing technologies and therapies. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects” and similar expressions are intended to identify forward-looking statements.

You are cautioned that forward-looking statements are inherently uncertain. Although CRISPR Therapeutics believes that such statements are based on reasonable assumptions within the bounds of its knowledge of its business and operations, forward-looking statements are neither promises nor guarantees and they are necessarily subject to a high degree of uncertainty and risk. Actual performance and results may differ materially from those projected or suggested in the forward-looking statements due to various risks and uncertainties. These risks and uncertainties include, among others: the outcomes for each CRISPR Therapeutics’ planned clinical trials and studies may not be favorable; that one or more of CRISPR Therapeutics’ internal or external product candidate programs will not proceed as planned for technical, scientific or commercial reasons; that future competitive or other market factors may adversely affect the commercial potential for CRISPR Therapeutics’ product candidates; uncertainties inherent in the initiation and completion of preclinical studies for CRISPR Therapeutics’ product candidates; availability and timing of results from preclinical studies; whether results from a preclinical trial will be predictive of future results of the future trials; uncertainties about regulatory approvals to conduct trials or to market products; uncertainties regarding the intellectual property protection for our technology and intellectual property belonging to third parties; and those risks and uncertainties described under the heading "Risk Factors" in CRISPR Therapeutics’ most recent annual report on Form 10-K, and in any other subsequent filings made by CRISPR Therapeutics with the U.S. Securities and Exchange Commission, which are available on its website. CRISPR Therapeutics disclaims any obligation or undertaking to update or revise any forward-looking statements on the Site, other than to the extent required by applicable law.

No Duty to Update

CRISPR Therapeutics will use reasonable efforts to keep information in the Site current and accurate, but makes no representations, warranties or assurances as to the accuracy, currency or completeness of the information provided. CRISPR Therapeutics disclaims any obligation to update the information contained on the Site as new data becomes available. CRISPR Therapeutics shall not be liable for any damages or injury resulting from a visitor’s ability or inability to access the Site, or from anyone's reliance on any information provided at the Site.

Links to Other Websites

Hyperlinks and references to other websites contained in the Site are provided only as a convenience to visitors of the Site, and do not imply CRISPR Therapeutics’ endorsement of material on any other website. CRISPR Therapeutics does not control the content of other websites. CRISPR Therapeutics makes no representations, warranties or assurances as to its knowledge of the contents of such other websites, or the accuracy, currency or completeness of any information, data, opinions, advice or statements provided therein. CRISPR Therapeutics shall not assume any responsibility for information obtained through hyperlinks or references to other websites contained in the Site, and shall not be liable for any damages or injury arising from the content of such other websites.

Location and Governing Law

CRISPR Therapeutics maintains the Site from its offices in Cambridge, Massachusetts, United States. The laws of the Commonwealth of Massachusetts shall govern these Terms of Use, without reference to its choice of law rules. Any action related to these Terms of Use shall be brought only in state or federal courts in the Commonwealth of Massachusetts. CRISPR Therapeutics makes no representation that the Site is appropriate or available for access in other locations, and access to the Site from territories where the content of the Site may be illegal is prohibited. Those who choose to access the Site from other locations do so on their own initiative, and are responsible for compliance with applicable laws to such access.

No Warranties

Your use of the Site and any linked websites is at your own risk. Neither CRISPR Therapeutics nor any other party involved in creating, producing or delivering the Site shall be liable for any direct, indirect, incidental or consequential damages arising out of your access to, or use of, the Site or any linked website. This includes damage due to viruses or other harmful or malicious code that may infect your computer equipment. You are responsible for taking all necessary precautions to ensure that any content you may obtain from the Site is free from malware, worms, viruses and other executable code. CRISPR Therapeutics makes no representations or warranties that use of the Site will be uninterrupted or error-free. CRISPR Therapeutics makes no warranty as to the accuracy, completeness, currency or reliability of any content available through the Site. You are responsible for verifying any information on the Site before relying on it. Use of the Site and the content available on the Site is at your sole risk. Without limiting the foregoing, EVERYTHING AT THE SITE IS PROVIDED TO YOU “AS IS” WITHOUT WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. Some jurisdictions do not allow the exclusion of implied warranties; therefore the above exclusion may not apply to you.

Limitation of Liability

Your use of the Site or any content on the Site is at your own risk. CRISPR Therapeutics specifically and expressly disclaims any and all liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential or special damages arising out of or in any way connected with access to or use of the Site, even if CRISPR Therapeutics or any affiliate or service provider thereof has been advised of the possibility of such damages, including but not limited to, reliance by any party on any content obtained through use of the Site, or that arises in connection with mistakes or omissions in or delays in transmission of information to or from the visitor, interruptions in telecommunications connections to the Site or viruses, whether caused in whole or in part by negligence, acts of God, telecommunications failure, theft or destruction of or unauthorized access (hackers) to the Site.

Indemnification

You shall indemnify CRISPR Therapeutics, and each of its directors, trustees, board members, officers, employees, affiliates and agents, for any and all liability, actions, proceedings, claims, demands, costs, expenses (including reasonable attorney’s fees), losses and damages whatsoever arising out of or in connection with your unauthorized or illegal use of the Site.

Severability

All of the Terms of Use are severable. If any provision of these Terms of Use is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of these Terms of Use shall remain in full force and effect. Any provision of these Terms of Use held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

Questions

If you have any questions about these Terms of Use, please contact info@crisprtx.com.

Last updated: November 1, 2018